Extension of a Pilot Study: Impact From the Cytochrome P450 2D6 Polymorphism on Outcome and Costs Associated With Severe Mental Illness-Reference-Cited by-同舟云学术

Extension of a Pilot Study: Impact From the Cytochrome P450 2D6 Polymorphism on Outcome and Costs Associated With Severe Mental Illness

Published:2000-04 Issue:2 Volume:20 Page:246-251
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:Journal of Clinical Psychopharmacology

Author:

Chou Wen Hwei,Yan Feng-Xiang,de Leon Jose,Barnhill John,Rogers Thea,Cronin Maureen,Pho Mylan,Xiao Vivian,Ryder Thomas B.,Liu Wei Wei,Teiling Clotilde,Wedlund Peter J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference28 articles.

1. Pilot Study of the Cytochrome P450-2D6 Genotype in a Psychiatric State Hospital

2. Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency

3. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics and Precision Psychiatry;Tasman’s Psychiatry;2024

2. Drug-drug interactions between COVID-19 drug therapies and antidepressants;Expert Opinion on Drug Metabolism & Toxicology;2023-11-30

3. Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients;Frontiers in Genetics;2023-08-25

4. Pharmacogenomics and Precision Psychiatry;Tasman’s Psychiatry;2023

5. Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic;Psychiatry and Clinical Neurosciences Reports;2022-06